Latest News
Greg Rhee, PhD, associate professor adjunct in psychiatry, and Samuel Wilkinson, MD, associate professor of psychiatry, are first and senior authors, respectively, of a paper in BMJ Mental Health that reviews the effects of electroconvulsive therapy on all-cause mortality and suicide deaths in severe unipolar or bipolar depression using longitudinal studies.
- October 10, 2025Source: WTNH-TV News 8
On World Mental Health Day on October 10, Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to WTNH-TV News 8 about mental health as the seasons change, and his work with ketamine for treatment-resistant depression.
- September 16, 2025Source: Newsweek
"The increase (in adults suffering from or being treated for depression) is alarming, and it is important that we keep an open mind and explore all possible causes," Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, told Newsweek in a recent interview.
- August 08, 2025
A mobile phone app designed to deliver suicide-specific therapy reduced suicidal behavior among high-risk psychiatric inpatients, according to a new study by scientists at Yale School of Medicine and The Ohio State University Wexner Medical Center and College of Medicine.
- July 14, 2025
The Yale Department of Psychiatry honored 21 residents at the annual Yale Psychiatry Residency Program commencement ceremony June 17 at the New Haven Lawn Club.
- July 07, 2025Source: The Washington Post
Psychiatrists John Krystal, MD, and Gerard Sanacora, MD, PhD spoke to The Washington Post about how SSRIs -- serotonin reuptake inhibitors -- can cause heat intolerance and how to stay safe on hot days.
- June 19, 2025Source: The New York Times
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The New York Times about the benefits and possible dangers associated with the use of ketamine to treat depression, suicidal ideation and chronic pain.
- April 24, 2025
A new clinical trial launched by scientists at Yale School of Medicine and University of California San Francisco may offer hope to people with Parkinson’s disease who suffer from depression.
- March 18, 2025Source: The New York Times
In a “taper,” patients encounter difficulties of two kinds: withdrawal, and the relapse of underlying conditions, explained Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, and director of the Yale Depression Research Program, in a story in The New York Times.
- February 21, 2025Source: JAMA Psychiatry
Researchers, including first author Samuel Wilkinson, MD, associate professor of psychiatry, and senior author Greg Rhee, PhD, associate professor adjunct in psychiatry, wrote in JAMA Psychiatry about the need to conduct clinical trials to prevent suicide.